Tevogen Inc. (TVGNW) stock

TVGNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGN

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30

$0.09+0.01 (+18.24%)

Close on Oct 30, 2026Market cap $38.42MP/E –Yield –

Tevogen price to free cash flow

Price to free cash flow is market cap divided by free cash flow over the trailing twelve months.

Tevogen has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.